Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of casein kinase 1α and cyclin dependent kinase 7/9 inhibition in patients with relapsed or refractory AML: A first-in-human study of BTX-A51
    Meeting Abstract

    Ball, B.; Borthakur, G.; Stein, A. S.; Chan, K.; Thai, D. L.; Stein, E.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Characterization of a novel radiohapten capture system in car T cells for tracking in vivo and improving CAR T efficacy
    Meeting Abstract

    Kurtz, K.; Dacek, M.; Cheal, S.; Veach, D.; Qureshy, S.; Carter, L.; Eibler, L.; Verma, S.; McDevitt, M.; Punzalan, B.; more...
    Human Gene Therapy (2022)

    Fulltext@MSK | Save
  • A radiohapten capture system for CAR T cells that tracks them in vivo and improves efficacy
    Meeting Abstract

    Kurtz, K.; Eibler, L.; Dacek, M.; Carter, L.; Cheal, S.; Veach, D.; Qureshy, S.; Han, J.; Reynaud, E.; Verma, S.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • A phase 2 study of itacitinib for the prevention of cytokine release syndrome (CRS) induced by immune effector cell (IEC) therapy: Preliminary results
    Meeting Abstract

    Frigault, M. J.; Maziarz, R. T.; Lazaryan, A.; Frey, N. V.; Assal, A.; Shah, N. N.; Lekakis, L. J.; Park, J. H.; Phillips, C. L.; Burke, L.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Functional testing to characterize and stratify PI3K inhibitor responses in chronic lymphocytic leukemia
    Journal Article

    Yin, Y. P.; Athanasiadis, P.; Karlsen, L.; Urban, A.; Xu, H. F.; Murali, I.; Fernandes, S. M.; Arribas, A. J.; Hilli, A. K.; Taskén, K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Subtype-specific 3D genome alteration in acute myeloid leukaemia
    Journal Article

    Xu, J.; Song, F.; Lyu, H.; Kobayashi, M.; Zhang, B.; Zhao, Z.; Hou, Y.; Wang, X.; Luan, Y.; Jia, B.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Real-world analysis of the safety/tolerability of gilteritinib in combination with mold-active azole prophylaxis
    Research Letter

    King, A. C.; Derkach, A.; Weis, T. M.; Stump, S. E.; Ciervo, J. R.; Ranaghan, C. P.; Stein, E. S.
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia
    Journal Article

    Flynn, K. E.; Atallah, E.; Lin, L.; Shah, N. P.; Silver, R. T.; Larson, R. A.; Pinilla-Ibarz, J.; Thompson, J. E.; Oehler, V. G.; Radich, J. P.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • PU.1-dependent enhancer inhibition separates Tet2-deficient hematopoiesis from malignant transformation
    Journal Article

    Aivalioti, M. M.; Bartholdy, B. A.; Pradhan, K.; Bhagat, T. D.; Zintiridou, A.; Jeong, J. J.; Thiruthuvanathan, V. J.; Pujato, M.; Paranjpe, A.; Zhang, C.; more...
    Blood Cancer Discovery (2022)

    Fulltext@MSK | Save